Alto Neuroscience is a biopharmaceutical company that develops biology-driven medicines for neuropsychiatric conditions. It offers the Precision Psychiatry Platform that uses biomarkers, machine learning, and neurobiology to treat bipolar depression, schizophrenia, and post-traumatic stress disorder (PTSD).